Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CORT Relative to the S&P 500

CORT Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Corcept Therapeutics Inc. (NASD:CORT) seasonal charts above shows that a Buy Date of August 24 and a Sell Date of November 17 has resulted in a geometric average return of 1.28% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return slightly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 0.5% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

To download CORT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CORT